Visual O O O O
Abstract O O O O
Abstract O O O O
Iron-deficiency O O O O
anemia O O O O
(IDA) O O O O
affects O O O O
many O O O O
infants O O O O
in O O O O
low- O O O O
and O O O O
middle-income O O O O
countries O O O O
(LMICs) O O O O
and O O O O
may O O O O
impair O O O O
cognitive O O O O
development O O O O
and O O O O
adaptive O O O O
immunity. O O O O
Effective O O O O
interventions O O O O
to O O O O
improve O O O O
iron O O O O
intakes O O O O
for O O O O
infants O O O O
in O O O O
LMICs O O O O
are O O O O
urgently O O O O
needed. O O O O
However, O O O O
absorption O O O O
of O O O O
oral O O O O
iron O O O O
fortificants O O O O
and O O O O
supplements O O O O
is O O O O
low, O O O O
usually O O O O
<10%, O O O O
and O O O O
most O O O O
of O O O O
the O O O O
iron O O O O
passes O O O O
into O O O O
the O O O O
colon O O O O
unabsorbed. O O O O
In O O O O
randomized O O O O
controlled O O O O
trials, O O O O
provision O O O O
of O O O O
iron O O O O
to O O O O
infants O O O O
in O O O O
LMICs O O O O
adversely O O O O
affects O O O O
their O O O O
gut O O O O
microbiome O O O O
and O O O O
increases O O O O
pathogenic O O O O
Escherichia O O O O
coli, O O O O
gut O O O O
inflammation, O O O O
and O O O O
diarrhea. O O O O
To Reason 1 O O
minimize Reason 1 O O
these Reason 1 O O
detrimental Reason 1 O O
effects Reason 1 O O
of Reason 1 O O
iron, Reason 1 O O
it Reason 1 O O
is Reason 1 O O
important Reason 1 O O
to Reason 1 O O
provide Reason 1 O O
the Reason 1 O O
lowest Reason 1 O O
effective Reason 1 O O
dosage Reason 1 O O
and Reason 1 O O
maximize Reason 1 O O
fractional Reason 1 O O
iron Reason 1 O O
absorption. Reason 1 O O
Prebiotic O O O O
galacto-oligosaccharides O O O O
and O O O O
apo-lactoferrin O O O O
may O O O O
prove O O O O
useful O O O O
in O O O O
iron O O O O
formulations O O O O
in O O O O
LMICs O O O O
because O O O O
they O O O O
increase O O O O
absorption O O O O
of O O O O
fortificant O O O O
iron O O O O
and O O O O
at O O O O
the O O O O
same O O O O
time O O O O
may O O O O
mitigate O O O O
the O O O O
adverse O O O O
effects O O O O
of O O O O
unabsorbed O O O O
iron O O O O
on O O O O
the O O O O
infant O O O O
gut. O O O O
Providing Reason 5 O O
well-absorbed Reason 5 O O
iron Reason 5 O O
early Reason 5 O O
in Reason 5 O O
infancy Reason 5 O O
may Reason 5 O O
improve Reason 5 O O
immune Reason 5 O O
function. Reason 5 O O
Recent O O O O
data O O O O
from O O O O
a O O O O
Kenyan O O O O
birth O O O O
cohort O O O O
suggest O O O O
IDA Reason 1 O O
at Reason 1 O O
the Reason 1 O O
time Reason 1 O O
of Reason 1 O O
infant Reason 1 O O
vaccination Reason 1 O O
impairs Reason 1 O O
the Reason 1 O O
response Reason 1 O O
to Reason 1 O O
diphtheria, Reason 1 O O
pertussis, Reason 1 O O
and Reason 1 O O
pneumococcus Reason 1 O O
vaccines. Reason 1 O O
A O O O O
randomized O O O O
trial O O O O
follow-up O O O O
study O O O O
reported O O O O
that O O O O
providing Reason 5 O O
iron Reason 5 O O
to Reason 5 O O
Kenyan Reason 5 O O
infants Reason 5 O O
at Reason 5 O O
the Reason 5 O O
time Reason 5 O O
of Reason 5 O O
measles Reason 5 O O
vaccination Reason 5 O O
increased Reason 5 O O
antimeasles Reason 5 O O
immunoglobulin Reason 5 O O
G Reason 5 O O
(IgG), Reason 5 O O
seroconversion, Reason 5 O O
and Reason 5 O O
IgG Reason 5 O O
avidity. Reason 5 O O
Because O O O O
IDA Reason 3 O O
is Reason 3 O O
so Reason 3 O O
common Reason 3 O O
among Reason 3 O O
infants Reason 3 O O
in Reason 3 O O
LMICs Reason 3 O O
and Reason 3 O O
because Reason 3 O O
the Reason 3 O O
vaccine-preventable Reason 3 O O
disease Reason 3 O O
burden Reason 3 O O
is Reason 3 O O
so Reason 3 O O
high, Reason 3 O O
even Reason 3 O O
if Reason 3 O O
IDA Reason 3 O O
only Reason 3 O O
modestly Reason 3 O O
reduces Reason 3 O O
immunogenicity Reason 3 O O
of Reason 3 O O
vaccines, Reason 3 O O
its Reason 3 O O
prevention Reason 3 O O
could Reason 3 O O
have Reason 3 O O
major Reason 3 O O
benefits. Reason 3 O O
